Clinical and Translational Radiation Oncology: 2024, vol: 45, issue:
1)- Raphael Bodensohn, Daniel F Fleischmann, Sebastian H Maier, Vasiliki Anagnostatou, Sylvia Garny, Alexander Nitschmann, Marcel Büttner, Johannes Mücke, Stephan Schönecker, Kristian Unger, Elgin Hoffmann, Frank Paulsen, Daniela Thorwarth, Adrien Holzgreve, Nathalie L Albert, Stefanie Corradini, Ghazaleh Tabatabai, Claus Belka, Maximilian Niyazi. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).Clinical and translational radiation oncology. 2024, 45: 100706
2)- Maiwand Ahmadsei, Vinojaa Jegarajah, Riccardo Dal Bello, Sebastian M Christ, Michael M Mayinger, Luisa Sabrina Stark, Jonas Willmann, Ivan R Vogelius, Panagiotis Balermpas, Nicolaus Andratschke, Stephanie Tanadini-Lang, Matthias Guckenberger. Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung Tumors.Clinical and translational radiation oncology. 2024, 45: 100707
3)- Lucas Schoenauen, François-Xavier Stubbe, Dirk Van Gestel, Sébastien Penninckx, Anne-Catherine Heuskin. : A potent model for high-throughput screening experiments investigating the FLASH effect.Clinical and translational radiation oncology. 2024, 45: 100712